Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
5.92
+0.02 (0.34%)
At close: Jul 7, 2026, 4:00 PM EDT
5.81
-0.11 (-1.85%)
After-hours: Jul 7, 2026, 5:59 PM EDT

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $65.84M in the quarter ending March 31, 2026, with 40.53% growth. This brings the company's revenue in the last twelve months to $204.73M, down -15.35% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%.

Revenue (ttm)
$204.73M
Revenue Growth
-15.35%
P/S Ratio
7.45
Revenue / Employee
$492,139
Employees
416
Market Cap
1.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.71B
Novavax596.34M
Innoviva420.69M
Immunocore Holdings412.81M
Septerna72.26M
Vir Biotechnology65.50M
Revenue Rankings